1. Home
  2. ONMD vs FGEN Comparison

ONMD vs FGEN Comparison

Compare ONMD & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$1.22

Market Cap

71.4M

Sector

N/A

ML Signal

HOLD

Logo FibroGen Inc

FGEN

FibroGen Inc

HOLD

Current Price

$9.02

Market Cap

35.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONMD
FGEN
Founded
2006
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.4M
35.6M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ONMD
FGEN
Price
$1.22
$9.02
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$146.50
AVG Volume (30 Days)
519.9K
41.0K
Earning Date
11-14-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
53.38
Revenue
$494,000.00
$8,298,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.17
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$4.85
52 Week High
$4.22
$21.94

Technical Indicators

Market Signals
Indicator
ONMD
FGEN
Relative Strength Index (RSI) 43.98 54.49
Support Level $1.04 $8.50
Resistance Level $1.28 $9.32
Average True Range (ATR) 0.15 0.56
MACD -0.01 0.10
Stochastic Oscillator 34.04 45.16

Price Performance

Historical Comparison
ONMD
FGEN

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's technology has provens the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade, image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols, paving the way for Real World Evidence.

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

Share on Social Networks: